Viewing nowEsomeprazole Magnesium Trihydrate 20 mg
Esomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
Os Koreia Pharmaceuticals Co., Ltd.

MFDS item code 202000181 · Approved 2020.01.13
Management of acid-related disorders and prevention of ulcer rebleeding; Helicobacter pylori eradication; treatment of gastrointestinal adverse effects caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease, especially erosive esophagitis, and for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It is also effective for symptom relief in patients with gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for eradication of Helicobacter pylori, as well as for the treatment and prevention of recurrence in patients with duodenal ulcers and peptic ulcers. It is indicated for the short-term treatment of upper gastrointestinal symptoms due to the use of non-steroidal anti-inflammatory drugs and for patients requiring continuous treatment to prevent gastric and duodenal ulcers. It is also used for the treatment of Zollinger-Ellison syndrome and as maintenance therapy to prevent rebleeding from gastric and duodenal ulcers after intravenous administration. Thus, it is effective in improving various symptoms and complications of gastrointestinal diseases.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg per dose once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for another 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg per dose once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have improved, control subsequent symptoms by administering 20 mg per dose once daily. · In adults, 20 mg per dose may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg per dose once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg per dose once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg per dose once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Older adults: No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg per dose once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for another 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg per dose once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have improved, control subsequent symptoms by administering 20 mg per dose once daily. · In adults, 20 mg per dose may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 3. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to certain patients. For example, patients who are allergic to this medication or any of its components, or have had hypersensitivity reactions, those allergic to penicillin antibiotics or macrolide antibiotics, patients taking certain heart-related medications, breastfeeding women, and patients with a history of myocardial infarction should not use this medication. This medication contains the dye Yellow No. 5, so individuals with allergies or hypersensitivity to this component should use it cautiously. This medication can cause various adverse reactions, so if symptoms such as headache, dizziness, abdominal pain, diarrhea, skin rash, muscle pain, or liver enzyme abnormalities occur, consult a doctor immediately. Serious skin reactions or blood abnormalities, though rare, have also been reported. Regular monitoring is required for long-term use of this medication, and if there are any changes in symptoms while taking the medication, consulting a doctor is essential. This medication has a high potential for drug interactions, so inform healthcare providers of any other medications being taken. Caution is particularly needed when used with antibiotics, antiviral drugs, anticoagulant medications, etc. The safety data for this medication during pregnancy is limited, so individuals who are pregnant or planning to become pregnant should consult with a physician before use. Breastfeeding women are advised not to take this medication, as information about its transmission into breast milk is insufficient. There are no special antidotes for overdose, so if symptoms arise, visit a healthcare facility immediately for appropriate treatment. This medication should be kept out of reach of children and should not be transferred to other containers.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, dysesthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia, systemic symptoms accompanied by drug reactions, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, general edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccup, melena, oral disorder, pharyngeal disorder, rectal disorder, gastrointestinal symptoms, increased serum gastrin, lingual disorder, tongue edema, ulcerative stomatitis, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormality, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremor, visual field defect, dysmenorrhea, menstrual disorder, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular eruption, otitis media, altered olfaction, ageusia, parageusia, urinary anomalies, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, mucosal discoloration, hernia, systemic lupus erythematosus, discoid lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius for optimal effectiveness.
Light pink round film-coated tablet
28 tablets/box [14 tablets/Alu-Alu×2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.25mg
Tablet · Prescription medication
Os Koreia Pharmaceuticals Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.